If you crack your phone screen, you don’t try to fix the cracks, you just replace the screen with a new one. In this, and many other cases, replacement is easier than repair. Critically, it may also be the case with aging.

Therapeutic replacement aims to solve aging by replacing aged tissues and organs with young ones. Instead of trying to understand every type of aging damage and repair it with a new drug, you can replace all types of damage at once. It doesn’t matter if a patch of skin is burned, infected, or cancerous; swap in new skin and all three problems vanish. This is important because aging is a combination of many types of damage, including types we don’t understand or haven’t even identified - replacement can solve all of them simultaneously with a single therapy.

So why aren’t we already using it to reverse aging? The biggest reason is supply constraints. Almost all replacement organs come from donors, and there are nowhere near enough to treat acute diseases, let alone aging. People wait years on lists; most never get the call. As long as organs are scarce, we need to ration them for the desperately sick.

Cells can be manufactured at scale, and used to great therapeutic benefit, however they sit in a scaffold of long-lived molecules called the ECM, and it ages too. It would be convenient if we could fully rejuvenate the body with cell therapies, but without major bioengineering breakthroughs in ECM repair, tissue-level replacement is the most feasible way to handle ECM aging.

But things would change if supply were unlimited. Suddenly the whole logic flips. You don’t wait for stage-5 kidney failure; you replace the kidney at stage 3, or give an aging-but-healthy person young organs before the heart attack instead of after. Medicine stops being reactive and becomes proactive. If you replace some tissues and organs, you may delay the onset of age-related disease. Replace enough and they may never occur at all. That is the world replacement is trying to build.

What already works

Replacement isn’t even a new idea. It’s already one of the most successful categories of medicine we have. Blood transfusions, artificial hips, and organ transplants are all replacement, all routine, all saving lives every day. When doctors don’t understand a liver disease, or don’t have a drug to treat it, they fall back to replacement.

A few example of replacement procedures already available, spanning every biological scale:

Organelles: healthy mitochondria can be transplanted into damaged tissue. In one trial, 8 of 10 critically ill children with heart damage were weaned off heart-lung life support after a mitochondrial transplant.
Cells: blood stem cells, immune cells, and new cell therapies for the heart, brain, and eyes are in the clinic or close to it.
Organs: hundreds of thousands of transplants happen every year, and when the donor is younger than the patient, the patient gets a little bit younger too.

The frontier is moving fast. A company called Humacyte just earned the first-ever FDA approval for a lab-grown blood vessel, proof that engineered human tissue can go all the way through the regulator to real patients. Genetically-edited pig organs have kept primates alive for a couple of years. And the U.S. government’s health-innovation agency is now funding a serious program aimed at replacing damaged brain tissue after stroke.

Where this is going: bodyoids, body transplants, and the brain

The endgame of the supply problem is to grow and unlimited supply of replacement parts instead of waiting for donors. The trick to achieving this is counterintuitive: a single organ is hard to grow in a jar, because organs are a team. The kidney expects the heart to pump and the lungs to breathe for it, so if you try to grow it alone you must artificially substitute all the functions of all the other organs. But if you grow most or all the organs together they can support each other, just like they evolved to. Grow enough of them and you approach what’s called a bodyoid: a young body, with organs, limbs, and blood, but deliberately engineered with no brain, so it can never become a person.

With a supply of young parts, the delivery question becomes surgical. And the surgery has a natural sweet spot: rather than transplant a dozen organs one at a time, you keep the patient’s head and give them a new body from the neck down. This is called a body transplant, and it has been tested to some extent in the lab, showing that the circulatory system of a new body can keep a head alive in various animals. Not only that, but cleanly cut spinal cords have been fused back together in animals that then learned to walk again. So while replacement bodies and the surgery to transplant them do not yet exist, we are seeing promising early signs that this technology could become reality.

That leaves the hardest and most personal part: the brain. The brain can’t be replaced all at once like a kidney because that would kill you. Instead, it must be replaced slowly, a small piece at a time, letting the brain’s natural ability to shift functions around (neuroplasticity) carry you through. It’s like the Ship of Theseus, replaced plank by plank while still sailing. Nobody has a finished answer here but the hope is that cell replacement, tissue replacement, or some combination can help keep the brain young and healthy.

The honest hard parts

Replacement has great potential, but it isn’t a silver bullet. There are several challenges that need to be addressed:

Supply: everything downstream waits on our ability to produce young cells, tissue, and body(oids) at scale. This is the most immediately limiting bottleneck and perhaps most readily solved.
Surgery: big transplants carry real mortality risk, which is why automated, robotic surgery matters so much.
Immune Tolerance: new parts must not be rejected. Newer techniques, like giving a bit of the donor’s bone marrow along with the transplant, are making off-the-shelf, drug-free compatibility look achievable, but we do not yet have a universal solution.
Brain Integration: normal brain growth happens in parallel, with all parts growing and forming connections following a genetic developmental program. Brain replacement needs to reproduce the formation of connections but between tissues of varying age (young naive tissue integrating with older mature tissue).

This may sound like a long, hard road, but the path is at least clear. The only question is how quickly we can make our way along it.

Where you come in

Aging is the most complicated problem in biology. Replacement is a shortcut around slow and expensive work to understand and repair it molecule by molecule. That is why, if it works, it will be the fastest path to defeating aging.

The obstacles are mostly engineering: supply and delivery. Engineering problems fall to money and effort, not to a lucky scientific miracle we can’t schedule. Work here will likely have real and substantial payoff.

If you’re a scientist or engineer, the highest-leverage work is on the supply side: growing organs, organ networks, and ideally bodyoids, plus the incubation and life-support systems to manage them.
If you’re a roboticist,surgeon or AI engineer, automated transplantation is the only way this ever reaches everyone. Help develop autonomous systems that make replacement safe and scalable.
If you’re a neuroscientist or neuro tech builder you can help with pre-clinical studies on brain tissue replacement, including developing methods for ensuring tissues connect properly.
If you’re a builder or funder, the industry is young and wide open. Near-term therapies (better microbiome, blood, mitochondrial, and ECM treatments) are already ready to commercialize, and many existing startups and new ones must be built and funded to solve the hard technical challenges .

Replacement is, at heart, a conceptually simple idea: replacing organs is often easier than curing disease. The obstacles are real, but they’re the kind we know how to knock down. So pick one, and help strike a mortal blow against aging.

Longevity Biotech Fellowship

Replacement: Solving Aging Without…